US Stem Cell Inc (USRM)

[Dragon Lady]

10-K, NEED ADDITIONAL FINANCING TO SURVIVE 2018..uh oh...

The company HAS NO PROFITS....thus NOTHING TO "WRITE OFF"...PERIOD..

They have NO FDA (or any govt agency) APPROVED PRODUCTS FOR SALE...NONE...their R&D was spent on Myocell....which has been DEFUNDED and DEADER THAN A BENT DOOR NAIL SINCE AROUND 2009....they've not conducted a LEGIT, FDA QUALITY CLINICAL TRIAL since Myocell trials were DEFUNDED/HALTED in approx 2009...DEAD..GOING and GONE NOWHERE....and no, they were not going to get "RMAT" when the freaking FDA has um under FORMAL FDA INVESTIGATION..not a chance in freaking hell that happens....they're about to get smacked BY THE FEDS if anything...TWO MAJOR FEDERAL AGENCIES now conducting formal investigations of this company...the FDA per a "FORMAL WARNING LETTER" that just got bumped up to the Sr Senator and CHAIRMAN OF THE FREAKING SENATE JUDICIARY COMMITTEE...one of the most powerful positions in this nation and now a FORMAL SEC INVESTIGATION via the SEC regional Miami office...started on March 1st, 2018 per their JUST FILED SEC 10-K...they be in some deep...deep...deep legal sh%^T...if you ask me....

https://www.sec.gov/Archives/edgar/data/1388319/000118518518000705/usstemcell10k123117.htm

They bes in troubles if you ask me....NOT LOOKING GOOD...gonna dilute...

PAGE 23:

"Risks Related to Our Financial Position and Need for Additional Financing

We will need to secure additional financing in 2018 in order to continue to finance our operations. If we are unable to secure additional financing on acceptable terms, or at all, we may be forced to curtail or cease our operations.

As of December 31, 2017, we had cash and cash equivalents of $986,799 and an accumulated capital deficit of $127,628,251. As such, our existing cash resources are insufficient to finance even our immediate operations.

Accordingly, we will need to secure additional sources of capital to develop our business and product candidates as planned. We are seeking substantial additional financing through public and/or private financing, which may include equity and/or debt financings, research grants and through other arrangements, including collaborative arrangements.

As part of such efforts, we may seek loans from certain of our executive officers, directors and/or current shareholders. We may also seek to satisfy some of our obligations to the guarantors of our loan with Seaside National Bank & Trust, or the Guarantors, through the issuance of various forms of securities or debt on negotiated terms. On January 3, 2018, the Company renewed the loan with Seaside National Bank and Trust extends the maturity date to May 11, 2018, all other terms and conditions remain unchanged. However, financing and/or alternative arrangements with the Guarantors may not be available when we need it, or may not be available on acceptable terms.

If we are unable to secure additional financing in the near term, we may be forced to:


•
curtail or abandon our existing business plans;

•
reduce our headcount;

•
default on our debt obligations;

•
file for bankruptcy;

•
seek to sell some or all of our assets; and/or

•
Cease our operations.

If we are forced to take any of these steps, any investment in our common stock may be worthless.

If we raise additional capital and/or secure alternative arrangements, with the Guarantors or otherwise, by issuing equity, equity-related or convertible securities, the economic, voting and other rights of our existing shareholders may be diluted, and those newly issued securities may be issued at prices that are a significant discount to current and/or then prevailing market prices. In addition, any such newly issued securities may have rights superior to those of our common stock. If we obtain additional capital through collaborative arrangements, we may be required to relinquish greater rights to our technologies or product candidates than we might otherwise have or become subject to restrictive covenants that may affect our business."

END QUOTE. HOLY COW !!

Well LOOKY THERE, ole Seaside Bank, their oldest loan that originated when they were headed to BK and being delisted by the NASDAQ, etc THEY ONLY RENEWED THE LOAN THIS TIME TILL MAY 2018.....B A D, BAD and DESPERATE...HOLY FREAKING COW. Seaside, in the past, would always renew the loan for ONE YEAR PERIODS as it was "secured" by the guarantors, aka Northstar Biotech LLC insiders...sounds like the bank don't trust the credit or credibility of this "company" anymore if you ask me...they call that loan and this POS IS BK faster than one can split...it's a $MILLION dollar loan and would be DUE AND PAYABLE...it'd put this mess in BK faster than a blink IMO..

MAY CEASE TO SURVIVE OR EXIST if..if..if they can't GET FINANCING SOON....REAL SOON (DILUTION..hello DILUTION)....this biz DOES NOT "MAKE IT" on their own...a loser and a money pit and a dilution machine...how much more CLEAR does it get than that.......